Telegdy G, Fekete M, Balázs M, Kádár T
Arch Int Pharmacodyn Ther. 1983 Nov;266(1):50-9.
The effects of a new antidepressant drug, EGYT-475 (1-benzyl-4-(2'-pyridylcarbonyl)-piperazine) on the acquisition and extinction of conditioned avoidance behavior following short and long-term treatment were studied in rats. The effects were compared with those of amitriptyline, imipramine and desipramine. In a six-day acquisition period, EGYT-475 in a 200 mg/kg dose p.o facilitated the acquisition, while amitriptyline, imipramine and desipramine either had no effect or impaired the acquisition, depending upon the dose used. In a six-day extinction period, EGYT-475 delayed the extinction following either oral or intraperitoneal administration, while amitriptyline, imipramine, and desipramine in various doses facilitated the extinction. On prolonged treatment the delayed extinction was maintained even after 42 days in animals treated with EGYT-475. The results indicate that EGYT-475, in contrast to tricyclic antidepressants, does not impair the acquisition of avoidance conditioning but rather improves it while it does not facilitate the extinction of learned behavior but considerably delays it.
研究了一种新型抗抑郁药物EGYT - 475(1 - 苄基 - 4 -(2'-吡啶甲酰基)哌嗪)对大鼠短期和长期治疗后条件性回避行为的获得和消退的影响。并将其与阿米替林、丙咪嗪和地昔帕明的效果进行了比较。在为期6天的行为获得期,口服200mg/kg剂量的EGYT - 475可促进行为获得,而阿米替林、丙咪嗪和地昔帕明根据所用剂量不同,要么没有效果,要么损害行为获得。在为期6天的消退期,口服或腹腔注射EGYT - 475均可延迟消退,而不同剂量的阿米替林、丙咪嗪和地昔帕明则促进消退。长期治疗后,用EGYT - 475治疗的动物即使在42天后仍保持延迟消退。结果表明,与三环类抗抑郁药相比,EGYT - 475不会损害回避条件反射的获得,反而会改善它,同时它不会促进习得行为的消退,而是会显著延迟消退。